Project: Small-molecule Novel Drug Ingredients Lab (RE.5.04.23-0268) – 150L Jacketed Glass Reactor
TBD Pharmatech’s recent procurement of 150L Jacketed glass reactor with thermostat, as part of the “Small-molecule Novel Drug Ingredients Lab” project, will add new capabilities to our organic synthesis services. This acquisition, funded by Enterprise Estonia (EAS) significantly enhances our capacity to conduct controlled, large-volume chemical reactions. The reactor is specifically designed for synthesizing complex chemical compounds, handling sensitive reaction conditions, and scaling up new product formulations. It is particularly effective for temperature-sensitive syntheses and multi-step organic processes, making it a critical asset for pioneering research and specialized chemical manufacturing. This upgrade will expand TBD Pharmatech’s portfolio of specialized services,
Read more